DOI QR코드

DOI QR Code

The P275A Polymorphism in the Macrophage Scavenger Receptor 1 Gene and Prostate Cancer Risk: a Meta-Analysis

  • Zhou, Qiao-Xia (West China School of Preclinical and Forensic Medicine, Sichuan University) ;
  • Tang, Jian-Qiu (West China School of Preclinical and Forensic Medicine, Sichuan University) ;
  • Zhao, Fen (Department of Oncology, Chengdu First People's Hospital) ;
  • Wei, Fu-Lin (West China School of Preclinical and Forensic Medicine, Sichuan University) ;
  • Huang, Ying (West China School of Preclinical and Forensic Medicine, Sichuan University)
  • Published : 2015.08.03

Abstract

Background: Published data regarding associations between the P275A polymorphism in the macrophage scavenger receptor 1 (MSR1) gene and prostate cancer (PCa) risk are inconclusive. The aim of this study was to comprehensively evaluate the genetic risk of P275A polymorphism in MSR1 gene for PCa. Materials and Methods: A systematic literature search was carried out in Pubmed, Medline (Ovid), Embase, CBM, CNKI, Weipu, and Wanfang databases, covering all available publications (last search was performed on Apr 27, 2015). Statistical analysis was performed using Revman 5.2 and STATA 10.1 software. Results: A total of 5,017 cases and 4,869 controls in 12 case-control studies were included in this meta-analysis. When all groups were pooled, there was no evidence that the P275A polymorphism had a significant association with PCa under dominant (OR=0.93, 95%CI=0.81-1.06, and p=0.28), co-dominant (homogeneous OR=0.97, 95%CI=0.56-1.68, and p=0.92; heterogeneous OR=0.93, 95%CI=0.74-1.15, and p=0.49), recessive (OR=1.10, 95%CI=0.65-1.87, and p=0.73), over-dominant (OR=0.93, 95%CI=0.75-1.15, and p=0.50), and allelic (OR=0.95, 95%CI=0.77-1.16, and p=0.61) genetic models. For stratified analyses by ethnicity and study design, no significant associations were found in the white race, the yellow race, the black race and mixed ethnicity, and the population-based case-control (PCC) and hospital-based case-control (HCC) studies under all genetic models. Conclusions: Based on our meta-analysis, the P275A polymorphism in the MSR1 gene is unlikely to be a risk factor for PCa.

Keywords

References

  1. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  2. Beuten J, Gelfond JA, Franke JL, et al (2010). Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men. Cancer Epidemiol Biomarkers Prev, 19, 588-99. https://doi.org/10.1158/1055-9965.EPI-09-0864
  3. Chen YC, Giovannucci E, Kraft P, et al (2008). Association between genetic polymorphisms of macrophage scavenger receptor 1 gene and risk of prostate cancer in the health professionals follow-up study. Cancer Epidemiol Biomarkers Prev, 17, 1001-3. https://doi.org/10.1158/1055-9965.EPI-07-0744
  4. Chokkalingam AP, Stanczyk FZ, Reichardt JK, et al (2007). Molecular epidemiology of prostate cancer: hormone-related genetic loci. Front Biosci, 12, 3436-60. https://doi.org/10.2741/2325
  5. Cybulski C (2007). Selected aspects of inherited susceptibility to prostate cancer and tumours of different site of origin. Hereditary Cancer Clin Pract, 5, 164-79. https://doi.org/10.1186/1897-4287-5-3-164
  6. Cybulski C, Wokolorczyk D, Jakubowska A, et al (2007). DNA variation in MSR1, RNASEL and E-cadherin genes and prostate cancer in Poland. Urol Int, 79, 44-9. https://doi.org/10.1159/000102913
  7. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
  8. Hsing AW, Chokkalingam AP (2006). Prostate cancer epidemiology. Front Biosci, 11, 1388-413. https://doi.org/10.2741/1891
  9. Hsing AW, Sakoda LC, Chen J, et al (2007). MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China. Carcinogenesis, 28, 2530-6. https://doi.org/10.1093/carcin/bgm196
  10. Hu Z-H, Lin Y-W, Xu X, et al (2013). Genetic polymorphisms of glutathione S-transferase M1 and prostate cancer risk in Asians: a meta-analysis of 18 studies. Asian Pac J Cancer Prev, 14, 393-8. https://doi.org/10.7314/APJCP.2013.14.1.393
  11. Krieger M, Herz J (1994). Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem, 63, 601-37. https://doi.org/10.1146/annurev.bi.63.070194.003125
  12. Lichtenstein P, Holm NV, Verkasalo PK, et al (2000). Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med, 343, 78-85. https://doi.org/10.1056/NEJM200007133430201
  13. Lindmark F, Jonsson BA, Bergh A, et al (2004). Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer. Prostate, 59, 132-40. https://doi.org/10.1002/pros.10367
  14. Maier C, Vesovic Z, Bachmann N, et al (2006). Germline mutations of the MSR1 gene in prostate cancer families from Germany. Hum Mutat, 27, 98-102. https://doi.org/10.1002/humu.20271
  15. Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
  16. Matshela RF, Maree JE, van Belkum C (2014). Prevention and detection of prostate cancer: a pilot intervention in a resource--poor South African community. Cancer Nurs, 37, 189-97. https://doi.org/10.1097/NCC.0b013e31829194d2
  17. Miller DC, Zheng SL, Dunn RL, et al (2003). Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men. Cancer Res, 63, 3486-9.
  18. Ostrander EA, Stanford JL (2000). Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet, 67, 1367-75. https://doi.org/10.1086/316916
  19. Platt N, Gordon S (2001). Is the class A macrophage scavenger receptor (SR-A) multifunctional?-The mouse's tale. J Clin Invest, 108, 649-54. https://doi.org/10.1172/JCI200113903
  20. Rennert H, Zeigler-Johnson C, Mittal RD, et al (2008). Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer. Urol, 72, 456-60. https://doi.org/10.1016/j.urology.2007.11.139
  21. Seppala EH, Ikonen T, Autio V, et al (2003). Germ-line alterations in MSR1 gene and prostate cancer risk. Clin Cancer Res, 9, 5252-6.
  22. Sun G-G, Wang Y-D, Lu Y-F, et al (2013). Different association of manganese superoxide dismutase gene polymorphisms with risk of prostate, esophageal, and lung cancers: evidence from a meta-analysis of 20, 025 subjects. Asian Pac J Cancer Prev, 14, 1937-43. https://doi.org/10.7314/APJCP.2013.14.3.1937
  23. Sun J, Hsu FC, Turner AR, et al (2006). Meta-analysis of association of rare mutations and common sequence variants in the MSR1 gene and prostate cancer risk. Prostate, 66, 728-37. https://doi.org/10.1002/pros.20396
  24. Wang L, McDonnell SK, Cunningham JM, et al (2003). No association of germline alteration of MSR1 with prostate cancer risk. Nat Genet, 35, 128-9. https://doi.org/10.1038/ng1239
  25. Wang M, Liu F, Hsing AW, et al (2012). Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium. Carcinogenesis, 33, 356-60. https://doi.org/10.1093/carcin/bgr279
  26. Wigginton JE, Cutler DJ, Abecasis GR (2005). A note on exact tests of Hardy-Weinberg equilibrium. Am J Human Genet, 76, 887-93. https://doi.org/10.1086/429864
  27. Xu J, Zheng SL, Hawkins GA, et al (2001). Linkage and association studies of prostate cancer susceptibility: evidence for linkage at 8p22-23. Am J Hum Genet, 69, 341-50. https://doi.org/10.1086/321967
  28. Xu J, Zheng SL, Komiya A, et al (2003). Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Am J Hum Genet, 72, 208-12. https://doi.org/10.1086/345802
  29. Xu J, Zheng SL, Komiya A, et al (2002). Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet, 32, 321-5. https://doi.org/10.1038/ng994
  30. Zhang H, Xu Y, Zhang Z, et al (2012). Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis. BMC immunol, 13, 14 https://doi.org/10.1186/1471-2172-13-14
  31. Zhang LL, Sun L, Zhu XQ, et al (2014). rs10505474 and rs7837328 at 8q24 cumulatively confer risk of prostate cancer in Northern Han Chinese. Asian Pac J Cancer Prev, 15, 3129-32. https://doi.org/10.7314/APJCP.2014.15.7.3129
  32. Zhao F, Cao Y, Zhu H, et al (2014). The-765G>C polymorphism in the cyclooxygenase-2 gene and digestive system cancer: a meta-analysis. Asian Pac J Cancer Prev, 15, 8301-10. https://doi.org/10.7314/APJCP.2014.15.19.8301

Cited by

  1. Shorter GGN Repeats in Androgen Receptor Gene Would Not Increase the Risk of Prostate Cancer vol.16, pp.2, 2017, https://doi.org/10.1177/1533034616673272